Table 2.
Phases Summary
Phase | Number of patients | Patients in the high-risk group, n (%) | Median MME prescribed | Median MME consumed | MME unused (%) | Number of patients requiring Refills | Satisfaction (%) |
---|---|---|---|---|---|---|---|
I | 16 | NA | 450 MME (range, 225-925) | N/A | N/A | 2 | 93% |
II | 23 | 2 (9%) | 550 MME (average risk), 900 MME (high risk) | 210 MME | 77% | 1 | 83% |
III | 22 | 2 (9%) | 290 MME (average risk), 450 MME (high risk) | 118 MME | 53% | 5 | 73% |
IV | 27 | 6 (22%) | 263 MME (average risk), 425 MME (high risk) | 98 MME | 58% | 2 | 93% |
Abbreviation: MME = oral morphine milligram equivalents.